CTNM
Contineum Therapeutics Inc.
$11.85
-$0.03(-0.25%)
54
Overall
60
Value
63
Tech
39
Quality
Market Cap
$319.40M
Volume
47.44K
52W Range
$3.35 - $20.24
Target Price
$22.33
Key Metrics Overview
| Market Cap | $319.40M | P/E Ratio | N/A |
| 52W High | $20.24 | 52W Low | $3.35 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 50.3% |
| Overall Score | 54 | Value Score | 60 |
| Quality Score | 39 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-2.39 | EPS Next Est | $-2.47 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $11.85 | -0.3% | 47.44K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW